Preclinical models revealed that Tscm—defined by the expression of CD45RA, CD45RO, and CD62L—had greater potential for self-renewal and pluripotent differentiation, longer persistence and greater anti-tumor activity compared to Tcm (34–36). Here, SELL is linked to neoplasm.